Related references
Note: Only part of the references are listed.The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Giovanni B. Frisoni et al.
NATURE REVIEWS NEUROSCIENCE (2022)
A comparison between MBP- and NT* as N-terminal fusion partner for recombinant protein production in E. coli
Sreejith Raran-Kurussi et al.
PROTEIN EXPRESSION AND PURIFICATION (2022)
Optimizing purification of the peripheral membrane protein FAM92A1 fused to a modified spidroin tag
Zuoneng Wang et al.
PROTEIN EXPRESSION AND PURIFICATION (2022)
Cryo-EM structures of amyloid-b 42 filaments from human brains
Yang Yang et al.
SCIENCE (2022)
NT*-HRV3CP: An optimized construct of human rhinovirus 14 3C protease for high-yield expression and fast affinity-tag cleavage
Elwy H. Abdelkader et al.
JOURNAL OF BIOTECHNOLOGY (2021)
Smallest Secondary Nucleation Competent Aβ Aggregates Probed by an ATP-Independent Molecular Chaperone Domain
Axel Leppert et al.
BIOCHEMISTRY (2021)
Protease resistance of ex vivo amyloid fibrils implies the proteolytic selection of disease-associated fibril morphologies
Jonathan Schoenfelder et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2021)
The expanding amyloid family: Structure, stability, function, and pathogenesis
Michael R. Sawaya et al.
CELL (2021)
Expression of the human molecular chaperone domain Bri2 BRICHOS on a gram per liter scale with an E. coli fed-batch culture
Benjamin Schmuck et al.
MICROBIAL CELL FACTORIES (2021)
High intracellular stability of the spidroin N-terminal domain in spite of abundant amyloidogenic segments revealed by in-cell hydrogen/deuterium exchange mass spectrometry
Margit Kaldmae et al.
FEBS JOURNAL (2020)
High-yield Production of Amyloid-β Peptide Enabled by a Customized Spider Silk Domain
Axel Abelein et al.
SCIENTIFIC REPORTS (2020)
Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
Sara Linse et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitro
Gefei Chen et al.
COMMUNICATIONS BIOLOGY (2020)
Why Aβ42 Is Much More Toxic than Aβ40
James C. Phillipse
ACS CHEMICAL NEUROSCIENCE (2019)
Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer's brain tissue
Marius Kollmer et al.
NATURE COMMUNICATIONS (2019)
A spidroin-derived solubility tag enables controlled aggregation of a designed amyloid protein
Medoune Sarr et al.
FEBS JOURNAL (2018)
BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells
Marie E. Oskarsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
On the role of sidechain size and charge in the aggregation of Aβ42 with familial mutations
Xiaoting Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Novel expression of a functional trimeric fragment of human SP-A with efficacy in neutralisation of RSV
Alastair Watson et al.
IMMUNOBIOLOGY (2017)
Fibril structure of amyloid-β(1-42) by cryo-electron microscopy
Lothar Gremer et al.
SCIENCE (2017)
Efficient protein production inspired by how spiders make silk
Nina Kronqvist et al.
NATURE COMMUNICATIONS (2017)
Bri2 BRICHOS client specificity and chaperone activity are governed by assembly state
Gefei Chen et al.
NATURE COMMUNICATIONS (2017)
Alzheimer's-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions
Maria Szaruga et al.
CELL (2017)
Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines
Jean D. Sipe et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2016)
Dementia-related Bri2 BRICHOS is a versatile molecular chaperone that efficiently inhibits Aβ42 toxicity in Drosophila
Helen Poska et al.
BIOCHEMICAL JOURNAL (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
The formation, function and regulation of amyloids: insights from structural biology
M. Landreh et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Molecular mechanisms of protein aggregation from global fitting of kinetic models
Georg Meisl et al.
NATURE PROTOCOLS (2016)
Atomic-resolution structure of a disease-relevant Aβ(1-42) amyloid fibril
Marielle Aulikki Walti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
In vivo aspects of protein folding and quality control
David Balchin et al.
SCIENCE (2016)
Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by A beta(1-40) and A beta(1-42)
David J. Lindberg et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
High Resolution Structural Characterization of Aβ42 Amyloid Fibrils by Magic Angle Spinning NMR
Michael T. Colvin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
Samuel I. A. Cohen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
Samuel I. A. Cohen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Interaction of the Molecular Chaperone DNAJB6 with Growing Arnyloid-beta 42 (Aβ42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation
Cecilia Mansson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides
Georg Meisl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Chemical kinetics for drug discovery to combat protein aggregation diseases
Paolo Arosio et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Samuel I. A. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
BRICHOS Domains Efficiently Delay Fibrillation of Amyloid β-Peptide
Hanna Willander et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
From Macroscopic Measurements to Microscopic Mechanisms of Protein Aggregation
Samuel I. A. Cohen et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Aggregation and fibril morphology of the Arctic mutation of Alzheimer's Aβ peptide by CD, TEM, STEM and in situ AFM
Nils Norlin et al.
JOURNAL OF STRUCTURAL BIOLOGY (2012)
Molecular consequences of amyloid precursor protein and presenilin mutations causing autosomal-dominant Alzheimer's disease
Sascha Weggen et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Binding of the Molecular Chaperone αB-Crystallin to Aβ Amyloid Fibrils Inhibits Fibril Elongation
Sarah L. Shammas et al.
BIOPHYSICAL JOURNAL (2011)
Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations
Samuel I. A. Cohen et al.
JOURNAL OF CHEMICAL PHYSICS (2011)
Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments
Samuel I. A. Cohen et al.
JOURNAL OF CHEMICAL PHYSICS (2011)
Structural polymorphism of Alzheimer Aβ and other amyloid fibrils
Marcus Fändrich et al.
Prion (2010)
Anti-Amyloid Activity of the C-Terminal Domain of proSP-C against Amyloid β-Peptide and Medin
Charlotte Nerelius et al.
BIOCHEMISTRY (2009)
Comparison of Alzheimer Aβ(1-40) and Aβ(1-42) amyloid fibrils reveals similar protofilament structures
Matthias Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
An Analytical Solution to the Kinetics of Breakable Filament Assembly
Tuomas P. J. Knowles et al.
SCIENCE (2009)
Mechanism of thioflavin T binding to amyloid fibrils
R Khurana et al.
JOURNAL OF STRUCTURAL BIOLOGY (2005)
The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation
C Nilsberth et al.
NATURE NEUROSCIENCE (2001)
Share Paper
